Bangladeshi - Kiingereza - DGDA (Directorate General of Drug Administration)

ambee pharmaceuticals ltd. - omeprazole - capsule - 20 mg

Bangladeshi - Kiingereza - DGDA (Directorate General of Drug Administration)

ambee pharmaceuticals ltd. - omeprazole - capsule - 40 mg

Australia - Kiingereza - APVMA (Australian Pesticides and Veterinary Medicines Authority)

raystar cropprotection pty ltd - 2,4-d present as the dimethylamine and diethanolamine sa - aqueous concentrate - 2,4-d present as the dimethylamine and diethanolamine sa phenoxy acids-2,4-d active 625.0 g/l - herbicide

Saudi - Kiingereza - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

om pharma s.a., portugal - patiromer sorbitex calcium - powder for oral suspension - 25.2 mg

Saudi - Kiingereza - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

om pharma s.a., portugal - patiromer sorbitex calcium - powder for oral suspension - 16.8 g

Saudi - Kiingereza - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

om pharma s.a., portugal - patiromer sorbitex calcium - powder for oral suspension - 8.4 g

Singapoo - Kiingereza - HSA (Health Sciences Authority)

pharma to market pte. ltd. - etamsylate - tablet - 500 mg - etamsylate 500 mg

Malesia - Kiingereza - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sunzen corporation sdn bhd - oxytetracycline dihydrate -

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - buprenorphine hydrochloride 2.16mg equivalent to 2 mg buprenorphine; naloxone hydrochloride dihydrate 0.61mg equivalent to 0.5 mg naloxone - sublingual tablet - 2mg/0.5mg - active: buprenorphine hydrochloride 2.16mg equivalent to 2 mg buprenorphine naloxone hydrochloride dihydrate 0.61mg equivalent to 0.5 mg naloxone excipient: acesulfame potassium citric acid lactose monohydrate lemon flavour phs-020484 magnesium stearate maize starch mannitol povidone sodium citrate dihydrate - treatment of opiate dependence, within a framework of medical, social and psychological treatment. naloxone is included in suboxone to deter intravenous misuse of the product.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - buprenorphine hydrochloride 8.64mg equivalent to 8 mg buprenorphine; naloxone hydrochloride dihydrate 2.44mg equivalent to 2 mg naloxone - sublingual tablet - 8mg/2mg - active: buprenorphine hydrochloride 8.64mg equivalent to 8 mg buprenorphine naloxone hydrochloride dihydrate 2.44mg equivalent to 2 mg naloxone excipient: acesulfame potassium citric acid lactose monohydrate lemon flavour phs-020484 magnesium stearate maize starch mannitol povidone sodium citrate dihydrate - treatment of opiate dependence, within a framework of medical, social and psychological treatment. naloxone is included in suboxone to deter intravenous misuse of the product.